Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalan. [electronic resource]
- Pharmacogenetics and genomics Jul 2007
- 505-17 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1744-6872
10.1097/FPC.0b013e3280ea77cd doi
Amino Acid Substitution Amino Acid Transport System y+--genetics Antineoplastic Agents, Alkylating--adverse effects Base Sequence DNA Primers--genetics Exons Fusion Regulatory Protein 1, Heavy Chain--genetics Fusion Regulatory Protein 1, Light Chains--genetics Genetic Variation Heterozygote Humans Introns Large Neutral Amino Acid-Transporter 1--genetics Lymphoma, Non-Hodgkin--drug therapy Melphalan--adverse effects Multiple Myeloma--drug therapy Pharmacogenetics Polymorphism, Genetic Promoter Regions, Genetic RNA, Messenger--genetics RNA, Neoplasm--genetics